期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 24, 期 9, 页码 964-969出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cmi.2018.03.030
关键词
Blood culture contaminations; Blood cultures; Coagulase-negative staphylococci; Contaminants; Prevention
资金
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Bloodstream Infections and Sepsis
- ESCMID Study Group for Staphylococci and Staphylococcal Diseases
- ESCMID Study Group for Epidemiological Markers
- ESCMID Study Group for Genomic and Molecular Diagnostics
- ESCMID Fungal Infections Study Group
Background: Despite the development of new microbiologic technologies, blood cultures (BCs) remain the first-line tool for the diagnosis of bloodstream infections. Their diagnostic value may be affected when a microorganism of questionable evidence is isolated-for example, coagulase-negative staphylococci, Bacillus spp., viridans group streptococci, Corynebacterium spp., Propionibacterium spp. and Micrococcus spp. Finally, making a correct diagnosis of pathogenicity (vs. contamination) is challenging. Aims: To review the current ways of dealing with the problem of BC contaminants (BCCs) and to provide practical suggestions to decrease BCC rates. Sources: PubMed electronic databases and existing reviews were searched up to December 2017 to retrieve relevant publications related to the topic. Contents: This review describes the burden of BCC and analyses the main current issues and controversies in interpreting the occurrence of potential BC contaminants. It focuses on the best-described approaches to decide whether BCC is present and discusses the different strategies of prevention in adults. (C) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据